GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
5,796
Funds Holding Change
+510
Funds Holding Growth
+10%
Value
$1.51T
Holding in Top 10
825
Top 10 Change
+261
Top 10 Growth
+46%
Value Growth
+28%
New
777
Increased
2,389
Reduced
2,304
Closed
154
Capital Inflow
$81.2B
Capital Outflow
$43B
Net Capital Flow
+$38.2B
Capital Flow Change
+$61.6B
Calls
$31.9B
Puts
$31.2B
Net Calls
+$789M
Put/Call Ratio
0.98